标题
Osteoprotegerin in Cardiometabolic Disorders
作者
关键词
-
出版物
International Journal of Endocrinology
Volume 2015, Issue -, Pages 1-15
出版商
Hindawi Limited
发表日期
2015-05-12
DOI
10.1155/2015/564934
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Serum Osteoprotegerin is Associated with Arterial Stiffness Assessed According to the Cardio-ankle Vascular Index in Hypertensive Patients
- (2015) Chung-Jen Lee et al. Journal of Atherosclerosis and Thrombosis
- Association of serum and vitreous concentrations of osteoprotegerin with diabetic retinopathy
- (2015) Gehua Yu et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Circulating osteoprotegerin is increased in the metabolic syndrome and associates with subclinical atherosclerosis and coronary arterial calcification
- (2014) Carmen Pérez de Ciriza et al. CLINICAL BIOCHEMISTRY
- Influence of pre-analytical and analytical factors on osteoprotegerin measurements
- (2014) C. Pérez de Ciriza et al. CLINICAL BIOCHEMISTRY
- Osteoprotegerin is independently associated with metabolic syndrome and microvascular complications in type 2 diabetes mellitus
- (2014) S Tavintharan et al. Diabetes & Vascular Disease Research
- RANKL–OPG and RAGE modulation in vascular calcification and diabetes: novel targets for therapy
- (2014) Agbor Ndip et al. DIABETOLOGIA
- Below-Knee Arterial Calcification in Type 2 Diabetes: Association With Receptor Activator of Nuclear Factor κB Ligand, Osteoprotegerin, and Neuropathy
- (2014) Olivier Bourron et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Increased Calcification in Osteoprotegerin-Deficient Smooth Muscle Cells: Dependence on Receptor Activator of NF-κB Ligand and Interleukin 6
- (2014) Andrea Callegari et al. JOURNAL OF VASCULAR RESEARCH
- Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes
- (2014) Stella Bernardi et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Association of serum osteoprotegerin with vascular calcification in patients with type 2 diabetes
- (2013) Atsushi Aoki et al. Cardiovascular Diabetology
- Serum Levels of Fetuin-A, Osteoprotegerin and Osteopontin in Patients with Coronary Artery Disease: Effects of Statin (HMGCoA-Reductase Inhibitor) Therapy
- (2013) Nikolaos P. E. Kadoglou et al. CLINICAL DRUG INVESTIGATION
- Osteoprotegerin: Multiple partners for multiple functions
- (2013) Marc Baud’huin et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Osteoprotegerin Is an Independent Predictor of Vascular Events in Finnish Adults With Type 1 Diabetes
- (2013) D. Gordin et al. DIABETES CARE
- Osteoprotegerin Exerts Its Pro-inflammatory Effects Through Nuclear Factor-κB Activation
- (2013) Lily Nahidi et al. DIGESTIVE DISEASES AND SCIENCES
- Association between osteoprotegerin gene polymorphisms and cardiovascular disease in type 2 diabetic patients
- (2013) Changlei Guo et al. GENETICS AND MOLECULAR BIOLOGY
- Effects of Combination Therapy With Olmesartan and Azelnidipine on Serum Osteoprotegerin in Patients With Hypertension
- (2013) Hiroyasu Uzui et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- The association of insulin resistance with serum osteoprotegerin in obese adolescents
- (2013) Joanna Suliburska et al. JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
- Mechanisms of Chronic State of Inflammation as Mediators That Link Obese Adipose Tissue and Metabolic Syndrome
- (2013) Eduardo Fuentes et al. MEDIATORS OF INFLAMMATION
- Osteoprotegerin as a Marker of Atherosclerosis in Diabetic Patients
- (2013) Areti Augoulea et al. International Journal of Endocrinology
- SNP rs2073618 of the Osteoprotegerin Gene Is Associated with Diabetic Retinopathy in Slovenian Patients with Type 2 Diabetes
- (2013) Sara Mankoč Ramuš et al. Biomed Research International
- Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications
- (2013) Mette Bjerre SpringerPlus
- The role of osteoprotegerin in cardiovascular disease
- (2012) Martina Montagnana et al. ANNALS OF MEDICINE
- Increased plasma osteoprotegerin concentrations in Type 1 diabetes with albuminuria
- (2012) Shen-tian Wang et al. CLINICAL NEPHROLOGY
- Role of the OPG/RANK/RANKL triad in calcifications of the atheromatous plaques: Comparison between carotid and femoral beds
- (2012) Marie-Françoise Heymann et al. CYTOKINE
- Osteoprotegerin, leptin and IL-6: Association with silent myocardial ischemia in type 2 diabetes mellitus
- (2012) Savas Guzel et al. Diabetes & Vascular Disease Research
- Prevalence and progression of peripheral vascular calcification in type 2 diabetes subjects with preserved kidney function
- (2012) Dhruv K. Singh et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The effect of exercise on osteoprotegerin and TNF-related apoptosis-inducing ligand in obese patients
- (2012) Colin Davenport et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- MECHANISMS IN ENDOCRINOLOGY: The endocrine role of the skeleton: background and clinical evidence
- (2012) Verena Schwetz et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Osteoprotegerin, but not osteopontin, as a potential predictor of vascular calcification in normotensive subjects
- (2012) Ewa Stępień et al. HYPERTENSION RESEARCH
- A comparison of osteoprotegerin with adiponectin and high-sensitivity C-reactive protein (hsCRP) as a marker for insulin resistance
- (2012) Eoin P. O'Sullivan et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Metabolic syndrome and inflammatory biomarkers: a community-based cross-sectional study at the Framingham Heart Study
- (2012) Dhayana Dallmeier et al. Diabetology & Metabolic Syndrome
- Osteoprotegerin promotes vascular fibrosis via a TGF-β1 autocrine loop
- (2011) Barbara Toffoli et al. ATHEROSCLEROSIS
- Rosiglitazone Decreases Plasma Levels of Osteoprotegerin in a Randomized Clinical Trial with Type 2 Diabetes Patients
- (2011) Mads Nybo et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Crystallizing nanoparticles derived from vascular smooth muscle cells contain the calcification inhibitor osteoprotegerin
- (2011) Michael Schoppet et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria
- (2011) Henrik Reinhard et al. Cardiovascular Diabetology
- Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men
- (2011) Weena JY Chen et al. Cardiovascular Diabetology
- Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus
- (2011) Mikael K Poulsen et al. Cardiovascular Diabetology
- Increased levels of bone remodeling biomarkers (osteoprotegerin and osteopontin) in hypertensive individuals
- (2011) Ewa Stępień et al. CLINICAL BIOCHEMISTRY
- The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism
- (2011) P. Ducy DIABETOLOGIA
- Osteoprotegerin is associated with cardiovascular risk in hypertension and/or diabetes
- (2011) Ana M. Blázquez-Medela et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- The Expression and Regulation of Bone-acting Cytokines in Human Peripheral Adipose Tissue in Organ Culture
- (2011) T. Harsløf et al. HORMONE AND METABOLIC RESEARCH
- Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy
- (2011) Yu-Hung Chang et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Adipocyte-secreted factors increase osteoblast proliferation and the OPG/RANKL ratio to influence osteoclast formation
- (2011) Markus C. Kühn et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Relationship between serum osteoprotegerin, glycemic control, renal function and markers of atherosclerosis in type 2 diabetes
- (2011) Alev E. Altinova et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Osteoprotegerin: A Biomarker With Many Faces
- (2010) Kenneth Caidahl et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Lovastatin raises serum osteoprotegerin level in people with type 2 diabetic nephropathy
- (2010) Nariman Nezami et al. CLINICAL BIOCHEMISTRY
- Osteoprotegerin and Mortality in Type 2 Diabetic Patients
- (2010) H. Reinhard et al. DIABETES CARE
- Increased osteoprotegerin levels in women with previous gestational diabetes developing metabolic syndrome
- (2010) Baris Akinci et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Osteoprotegerin and biomarkers of vascular inflammation in type 2 diabetes
- (2010) Eoin P. O'Sullivan et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Plasma osteoprotegerin concentrations in peripheral sensory neuropathy in Type 1 and Type 2 diabetic patients
- (2010) M. Nybo et al. DIABETIC MEDICINE
- Effect of pioglitazone on serum concentrations of osteoprotegerin in patients with type 2 diabetes mellitus
- (2010) Jong Suk Park et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Osteoprotegerin as a Predictor of Coronary Artery Disease and Cardiovascular Mortality and Morbidity
- (2010) Shreenidhi M. Venuraju et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Evidence for markers of hypoxia and apoptosis in explanted human carotid atherosclerotic plaques
- (2010) Alessandra Bitto et al. JOURNAL OF VASCULAR SURGERY
- Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects
- (2010) David T. Ashley et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Does osteoprotegerin relate to micro- and macrovascular complications in long-term type 1 diabetes?
- (2010) Jakob Grauslund et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Low serum osteoprotegerin levels in normoalbuminuric type 1 diabetes mellitus
- (2009) Dhruv K. Singh et al. ACTA DIABETOLOGICA
- A Single-Nucleotide Polymorphism in the Gene Encoding Osteoprotegerin Is Associated With Diastolic Blood Pressure in Older Men
- (2009) Jonathan Golledge et al. AMERICAN JOURNAL OF HYPERTENSION
- Effects of Pravastatin on Serum Osteoprotegerin Levels in Patients With Hypercholesterolemia and Type 2 Diabetes
- (2009) Katsuhito Mori et al. ANGIOLOGY
- Evidence of a colocalisation of osteoprotegerin (OPG) with von Willebrand factor (VWF) in platelets and megakaryocytes alpha granules. Studies from normal and grey platelets
- (2009) Maria-Eugenia Chollet et al. BRITISH JOURNAL OF HAEMATOLOGY
- Associations of coronary artery calcification and carotid intima-media thickness with plasma concentrations of vascular calcification inhibitors in type 2 diabetic patients
- (2009) Masami Ishiyama et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study
- (2009) A. A. Mahabadi et al. EUROPEAN HEART JOURNAL
- Acute hyperinsulinemia decreases plasma osteoprotegerin with diminished effect in type 2 diabetes and obesity
- (2009) Gitte Maria Jørgensen et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucose
- (2009) Dag Hofsø et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- OPG/RANK/RANKL signaling system and its significance in nephrology.
- (2009) Katarzyna Klejna et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- Human Full-Length Osteoprotegerin Induces the Proliferation of Rodent Vascular Smooth Muscle Cells both in vitro and in vivo
- (2009) Riccardo Candido et al. JOURNAL OF VASCULAR RESEARCH
- Osteoprotegerin in relation to type 2 diabetes mellitus and the metabolic syndrome in postmenopausal women
- (2009) Iraj Nabipour et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Release of 12 Adipokines by Adipose Tissue, Nonfat Cells, and Fat Cells From Obese Women
- (2009) John N. Fain et al. Obesity
- Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function
- (2008) Joseph S. McGonigle et al. ANGIOGENESIS
- Functions of RANKL/RANK/OPG in bone modeling and remodeling
- (2008) Brendan F. Boyce et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Osteoprotegerin, vascular calcification and atherosclerosis
- (2008) Ann Van Campenhout et al. ATHEROSCLEROSIS
- Osteoprotegerin Inhibits Vascular Calcification Without Affecting Atherosclerosis in ldlr (−/−) Mice
- (2008) Sean Morony et al. CIRCULATION
- Relationship of elevated osteoprotegerin with insulin resistance, CRP, and TNF-α levels in men with type 2 diabetes
- (2008) Subhashini Yaturu et al. CYTOKINE
- Serum osteoprotegerin is associated with carotid intima media thickness in women with previous gestational diabetes
- (2008) Baris Akinci et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy
- (2008) A. Jorsal et al. DIABETOLOGIA
- Pathophysiological roles of osteoprotegerin (OPG)
- (2008) Penny Reid et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Osteoprotegerin in relation to body weight, lipid parameters insulin sensitivity, adipocytokines, and C-reactive protein in obese and non-obese young individuals: results from both cross-sectional and interventional study
- (2008) Marie-Hélène Gannagé-Yared et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Plasma Osteoprotegerin Concentrations in Type 2 Diabetic Patients and its Association with Neuropathy
- (2008) H. Terekeci et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Evidence of a Role for Osteoprotegerin in the Pathogenesis of Pulmonary Arterial Hypertension
- (2007) Allan Lawrie et al. AMERICAN JOURNAL OF PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More